52 related articles for article (PubMed ID: 21499126)
1. Modulation of the poliovirus receptor expression in malignant lymphocytes by epigenetic alterations.
Wang W; Gao L; Wang X; Kang H; Li Y; Wang L; Yu L
J Immunother; 2011 May; 34(4):353-61. PubMed ID: 21499126
[TBL] [Abstract][Full Text] [Related]
2. [Poliovirus receptor on surface of acute B lymphoid leukemia cells modulated by epigenetic mechanism].
Wang W; Gao L; Wang XR; Kang HY; Li YH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1357-61. PubMed ID: 22169283
[TBL] [Abstract][Full Text] [Related]
3. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors suppress natural killer cell cytolytic activity.
Ogbomo H; Michaelis M; Kreuter J; Doerr HW; Cinatl J
FEBS Lett; 2007 Apr; 581(7):1317-22. PubMed ID: 17349632
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors prevent activation of tumour-reactive NK cells and T cells but do not interfere with their cytolytic effector functions.
Schmudde M; Friebe E; Sonnemann J; Beck JF; Bröker BM
Cancer Lett; 2010 Sep; 295(2):173-81. PubMed ID: 20346580
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
[TBL] [Abstract][Full Text] [Related]
9. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
Bridges KR; Smith BR
J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
[TBL] [Abstract][Full Text] [Related]
10. The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells.
Feng X; Yan J; Wang Y; Zierath JR; Nordenskjöld M; Henter JI; Fadeel B; Zheng C
Mol Immunol; 2010 Aug; 47(14):2388-96. PubMed ID: 20542572
[TBL] [Abstract][Full Text] [Related]
11. Demethylating treatment suppresses natural killer cell cytolytic activity.
Gao XN; Lin J; Wang LL; Yu L
Mol Immunol; 2009 Jun; 46(10):2064-70. PubMed ID: 19394699
[TBL] [Abstract][Full Text] [Related]
12. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of gelsolin expression in human breast cancer cells.
Mielnicki LM; Ying AM; Head KL; Asch HL; Asch BB
Exp Cell Res; 1999 May; 249(1):161-76. PubMed ID: 10328963
[TBL] [Abstract][Full Text] [Related]
14. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
Wang Y; Fan PS; Kahaleh B
Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.
Castriconi R; Dondero A; Corrias MV; Lanino E; Pende D; Moretta L; Bottino C; Moretta A
Cancer Res; 2004 Dec; 64(24):9180-4. PubMed ID: 15604290
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
18. Plasticity of Ly49g expression is due to epigenetics.
Rouhi A; Brooks CG; Takei F; Mager DL
Mol Immunol; 2007 Feb; 44(5):821-6. PubMed ID: 16750269
[TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines.
Xu Y; Voelter-Mahlknecht S; Mahlknecht U
Int J Mol Med; 2005 Jan; 15(1):169-72. PubMed ID: 15583844
[TBL] [Abstract][Full Text] [Related]
20. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
Bhakat KK; Mitra S
Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
